pCMV-HA-hIFITM3 Citations (2)

Originally described in: Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC Nat Chem Biol. 2010 Aug;6(8):610-4. doi: 10.1038/nchembio.405. Epub 2010 Jul 4. PubMed Journal

---

Articles Citing pCMV-HA-hIFITM3

Articles
IFITM proteins inhibit the late step of feline foamy virus replication. Kim J, Shin CG. Anim Cells Syst (Seoul). 2020 Sep 15;24(5):282-288. doi: 10.1080/19768354.2020.1819413. PubMed
IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC. Cui Y, Qiu T, Wang J, Liu X, Luo L, Yin J, Zhi X, Wang W, Feng G, Wu C, Zhao Z, Zhang H, Li F, Wu F, Ren S. Mol Cancer. 2025 Jul 3;24(1):187. doi: 10.1186/s12943-025-02383-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.